Extending Survival

Switching from Abiraterone Plus Prednisone to Abiraterone Plus Dexamethasone Can Extend Its Effectiveness

Switching from Abiraterone Plus Prednisone to Abiraterone Plus Dexamethasone Can Extend Its Effectiveness

A timed steroid switch from prednisone to dexamethasone appears to be a safe and non‐expensive way of obtaining long‐term responses to Zytiga in selected men with metastatic castrate resistant prostate cancer (mCRPC).